Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-21 Purchase |
2024-10-23 7:49 pm |
Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director |
145,000 | $1.37 | $198,650 | 205,000 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:42 pm |
RayzeBio Inc. | RYZB | Kush Arvind CHIEF FINANCIAL OFFICER |
78,433 | $62.5 | $4,902,063 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Option Award |
2025-02-19 8:19 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director |
173,185 | $0 | 173,185 (Direct) |
View |
| 2024-10-21 Option Award |
2024-10-23 7:49 pm |
N/A 2034-10-21 |
Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director |
60,000 | $0 | 205,000 (Direct) |
View |
| 2023-11-17 Option Award |
2023-11-17 6:38 pm |
N/A 2033-11-16 |
RayzeBio Inc. | RYZB | Kush Arvind Chief Financial Officer |
164,000 | $0 | 164,000 (Direct) |
View |
Ownership |
2023-09-14 7:39 pm |
N/A N/A |
RayzeBio Inc. | RYZB | Kush Arvind Chief Financial Officer |
0 | $0 | 529,079 (Direct) |
View |